2 results
Approved WMOWill not start
To collect long term data on safety and tolerability of dovitinib monotherapy.
Approved WMOCompleted
Primary: treatment effect of TKI258 in combination with fulvestrant vs. fulvestrant plus placebo on Progression-Free Survival (voor for each of the 2 groups, namely FGF pathway amplified and regardless of FGF pathway amplification status).Secondary…